GGrantIndex
Sort

261,768 grants matching gene therapy

Wisconsin Registry for Alzheimer's Prevention: Biomarkers for Preclinical AD

$860,098
Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2017 · AG

Wisconsin Registry for Alzheimer's Prevention: Biomarkers for Preclinical AD

$860,098
Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2016 · AG

Wisconsin Registry for Alzheimer's Prevention: Biomarkers for Preclinical AD

$860,098
Sterling C Johnson · University Of Wisconsin-Madison · R01 · FY2014 · AG

High Throughput Protein-Protein Interaction Interrogation in Cancer

$860,078
Haian Fu · Emory University · U01 · FY2016 · CA

Molecular investigations of HIV-1 maturation pathways and inhibitor actions in situ

$859,992
Yong Xiong · Yale University · R01 · FY2025 · AI

Kidney targeted AAV for gene therapy

$859,980
Matthew H Wilson · Vanderbilt University Medical Center · R01 · FY2025 · DK

Anthipertensive PharmacoGenomics

$859,934
Mayo Clinic · R01 · FY2005 · HL

Anthipertensive PharmacoGenomics

$859,934
Mayo Clinic · R01 · FY2004 · HL

Understanding IDH mutant gliomas

$859,926
Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Activated protein C mechanisms of brain white matter protection and new therapies for brain white matter ischemic injury

$859,919
Berislav V Zlokovic · University Of Southern California · R01 · FY2020 · NS

Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)

$859,902
Michael John McGeachie · Brigham And Women'S Hospital · R01 · FY2022 · HL

Control of Autoimmunity by Regulatory T Cells

$859,901
Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

The regulatory role of natural progesterone in barrier immunity

$859,848
Florian Hladik · University Of Washington · R01 · FY2024 · AI

Epigenetics, Stem Cells, and Cancer

$859,815
Rudolf Jaenisch · Whitehead Institute For Biomedical Res · R01 · FY2006 · CA

Combined radio- and immunotherapy of aggressive NHL

$859,792
William A. Wegener · Immunomedics, Inc. · R44 · FY2009 · CA

Regulation of y-secretase activity by modulatory proteins

$859,767
Yueming Li · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG

Genome-Wide Association Study in Celiac Disease

$859,753
Chad P Garner · University Of California-Irvine · R01 · FY2011 · DK

A randomized double-blind, placebo-controlled phase 2 clinical trial of intravenous citrulline for vaso-occlusive crisis in sickle cell disease

$859,704
Suvankar Majumdar · Children'S Research Institute · R33 · FY2025 · HL

Agr2 regulates host-microbe responses in Crohn's disease

$859,704
Randy S Longman · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DK

Signal and Transcription Factor Network interactions in Head and Neck Cancer

$859,666
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2014 · DC

NF-kappaB in pathogenesis and therapy of head and neck cancer

$859,665
Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2014 · DC

Multi-Site Validation of Biomarkers and Core Clinical Outcome Measures for Clinical Trials Readiness in CDKL5 Deficiency Disorder

$859,629
Timothy A Benke · University Of Colorado Denver · U01 · FY2024 · NS

CANCER DRUGS ACTIVE AGAINST SIGNAL TRANSDUCTION TARGETS

$859,609
University Of Arizona · U19 · FY2000 · CA

ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)

$859,607
Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2020 · CA

Phenotypic and genetic architecture of OCD in African Americans

$859,577
Dorothy E Grice · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH